Navigation Links
Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
Date:6/20/2011

NEW YORK, June 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

http://www.reportlinker.com/p0558482/Global-Hemostasis-Diagnostics-Market-US-Europe-Japan--Emerging-Opportunities-and-Business-Expansion-Strategies-for-Suppliers.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the hemostasis diagnostics market during this decade.

The report explores business and technological trends in world's seven major markets; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the hemostasis diagnostics practice during the next ten years.

New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Geographic Coverage

- France

- Germany

- Italy

- Japan

- Spain

- UK

- USA

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

- Hospitals

- Commercial/Private Laboratories

- Physician Offices

- Ambulatory Care Clinics.

- The 2010, 2015 and 2020 test forecasts for 40 major procedures, by country and market segment.

Current and Emerging Products

- Review of over 40 established and new procedures.

- Comparison of over 50 automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex, Trinity Biotech and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applicants.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Worldwide Market Overview

- Estimates of facilities performing hemostasis diagnostic tests, by country.

- Test volume and sales projections by country.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- "Ideal" product models with tentative prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, and Venture Planning Group's proprietary data files was conducted.

Contains 650 pages and 150 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Routine and Special Hemostasis Tests

1. Introduction

2. Activated Partial Thromboplastin Time (APTT)

3. Alpha-2 Antiplasmin

4. Antithrombin III

5. Bleeding Time

6. D-Dimer

7. Ethanol Flocculation Test

8. Euglobulin Lysis

9. Factor Assays

a. Introduction

b. Factor II

c. Factor V/Factor V Leiden

d. Factor VII

e. Factor VIII

f. Factor IX

g. Factor IXa

h. Factor X (Stuart Factor)

i. Factor Xa

j. Factor XI

k. Factor XII

l. Factor XIII

10. Fibrin Degradation Products

11. Fibrinogen

12. Heparin

13. Hirudin

14. Hypercoagulability and Thrombosis

15. Lipoprotein a

16. Plasmin

17. Plasminogen

18. Plasminogen Activator Inhibitor (PAI)

19. Platelet Function Tests

20. Platelet Aggregation

21. Proteins C and S

22. Prothrombin Fragment 1.2

23. Prothrombin Time (PT)

24. Reptilase Time

25. Thrombin Time

26. Tissue-Type Plasminogen Activator (t-PA)

27. Von Willebrand's Factor

B. Instrumentation Review

- Introduction

- Benk Hemolab

- Benk TRT Thrombotimer

- Bio/Data MCA 310

- Bio/Data MCA 210

- Bio/Data PAP-4C D/4D/4C

- Cardiovascular Diagnostics COAG

- Diagnostica Stago STA Compact

- Diagnostica Stago STA-R

- Diagnostica Stago Star 4/8

- Helena Laboratories Cascade 480

- Helena Laboratories Cascade M

- Helena Laboratories PACKS-4

- Helena THOR

- Instrumentation Laboratory ACL 100 and 1000 series

- Instrumentation Laboratory ACL6000

- Instrumentation Laboratory ACL7000

- Instrumentation Laboratory ACL9000

- Instrumentation Laboratory Electra 1000C

- Instrumentation Laboratory Electra 1400C

- Instrumentation Laboratory Electra 1600/C

- Instrumentation Laboratory Electra 1800C

- Instrumentation Laboratory Futura

- ITC Hemochron 8000

- Roche Diagnostics CoaguChek

- Siemens BCS

- Siemens BCT

- Siemens BF II/Fibrintimer Series

- Sysmex CA-50

- Sysmex CA-500

- Sysmex CA-1500

- Sysmex CA-5000/CA-1000

- Sysmex CA-6000

- Sysmex CA-7000

- Teco Coatron II/Jr./AccuStasis 5000

- Trinity Biotech Amax CS190

- Trinity Biotech Amax CS400

- Trinity Biotech Coag-A-Mate Max

- Trinity Biotech KC 40, 4A, 1A Series

- Trinity Biotech MDA 180

- Trinity Biotech Coag-A-Mate MTX

- Trinity Biotech Coag-A-Mate RA4

- Trinity Biotech Coag-A-Mate XC/Plus

- Trinity Biotech Coag-A-Mate XM

C. Major in Vitro Diagnostic Technologies and Their

Potential Applications

1. Chromogenic Substrates

2. Monoclonal and Polyclonal Antibodies

3. Immunoassays

a. Applications

b. Technological Principle

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- EMIT

- Dot Immunobinding Assays

- Capillary Immunoassays

- Enzyme Amplification

- Electrochemical Immunoassay

d. Fluorescent Immunoassays

- Fluorescence Polarization

- Time-Resolved Pulse Fluorescence

- Fluorescence Lifetime

e. Latex Agglutination

f. Immunoprecipitation

4. Microcomputers

5. Automation

6. Robotics

7. DNA Probes

a. Overview

b. Amplification Methods

- PCR

- Ligase Chain Reaction

- Branched DNA

- Q-Beta Replicase

- NASBA

- SDA

- 3 SR

- HPA

- Two-Tiered System

- LAT

8. Artificial Intelligence

9. Dry Chemistry

10. Biosensors

D. Worldwide Market Overview

1. Business Environment

2. Market Structure

3. Market Size and Growth

4. POC Testing Market

France

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Germany

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Italy

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Japan

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Spain

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

UK

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

USA

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Industry Consolidation

4. Managed Care

5. Hospitals

6. Admissions

7. Length of Stay

8. Industry Diversification

9. Physician Demographics

10. Population Aging

a. Chronic Illnesses

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

11. Laboratory Regulations

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial laboratories

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point-of-Care Testing

c. Home/Self Testing

d. Other Decentralized Testing Locations

D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

- Abbott

- American Diagnostica

- Avocet Medical

- Axis-Shield

- Beckman Coulter

- Becton Dickinson

- Bio/Data Corporation

- Biosite

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago

- Helena Laboratories

- HYPEN BioMed

- Instrumentation Laboratory

- ITC

- Nanogen

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fischer

- Trinity Biotech

- ZyCare

List of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests

Major Companies Developing or Marketing APTT Tests

Major Companies Developing or Marketing Alpha-2 Antiplasmin

Tests

Major Companies Developing or Marketing Antithrombin III Tests

Major Companies Developing or Marketing Bleeding Time Tests

Major Companies Developing or Marketing D-dimer Tests

Major Companies Developing or Marketing Factor Assays

Major Companies Developing or Marketing Fibrin Degradation

Product Tests

Major Companies Developing or Marketing Fibrinogen Tests

Major Companies Developing or Marketing Heparin Tests

Major Companies Developing or Marketing Plasmin Tests

Major Companies Developing or Marketing Plasminogen Tests

Major Companies Developing or Marketing Plasminogen Activator

Inhibitor Tests

Major Companies Developing or Marketing Platelet Aggregation

Tests

Major Companies Developing or Marketing Protein C Tests

Major Companies Developing or Marketing Protein S Tests

Major Companies Developing or Marketing PT Tests

Major Companies Developing or Marketing Thrombin Time Tests

Major Companies Developing or Marketing TPA Tests

Major Companies Developing or Marketing Von Willebrand's

Factor Tests

Worldwide, All Market Segments, Laboratories Performing

Hemostasis Tests By Country, 2010

Worldwide, All Market Segments, Total Hemostasis Test Volume

By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Reagent

Market By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Instrument

Market By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Diagnostics

Market By Country, 2010-2020

Executive Summary Table: France, Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

France, Laboratories Performing Hemostasis Tests By Market

Segment, 2010

France, Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

France, Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

France, Hospital Laboratories Average Daily Test Volume, 2010

France, Commercial/Private Laboratories Average Daily Test

Volume, 2010

France, Total Hemostasis Test Volume By Market Segment,

2010-2020

France, All Market Segments Hemostasis Test Volume,

2010-2020

France, Hospital Laboratories Hemostasis Test Volume,

2010-2020

France, Commercial/Private Laboratories Hemostasis Test Volume,

2010-2020

France, Hemostasis Reagent Market By Market Segment,

2010-2020

France, Major Suppliers of Hemostasis Reagents Estimated Sales

and Market Shares, 2010

France, Hemostasis Instrument Market By Market Segment,

2010-2020

France, Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

France, Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

France, Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

France, Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

France, Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

Executive Summary Table: Germany, Total Hemostasis

Diagnostics Market By Market Segment and Product Category,

2010-2020

Germany, Laboratories Performing Hemostasis Tests By Market

Segment, 2010

Germany, Hospital Laboratories Performing Hemostasis Tests

By Bed Size, 2010

Germany, Commercial/Private Laboratories Performing

Hemostasis Tests By Annual Test Volume, 2010

Germany, Hospital Laboratories Average Daily Test Volume, 2010

Germany, Commercial/Private Laboratories Average Daily Test

Volume, 2010

Germany, Physician Offices/Group Practice Average Daily Test

Volume, 2010

Germany, Total Hemostasis Test Volume By Market Segment,

2010-2020

Germany, All Market Segments Hemostasis Test Volume,

2010-2020

Germany, Hospital Laboratories Hemostasis Test Volume,

2010-2020

Germany, Commercial/Private Laboratories Hemostasis Test

Volume, 2010-2020

Germany, Physician Offices/Group Practices Hemostasis Test

Volume, 2010-2020

Germany, Hemostasis Reagent Market By Market Segment,

2010-2020

Germany, Major Suppliers of Hemostasis Reagents, Estimated

Sales and Market Shares, 2010

Germany, Hemostasis Instrument Market By Market Segment,

2010-2020

Germany, Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

Germany, Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

Germany, Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

Germany, Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

Germany, Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

Executive Summary Table: Italy, Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

Italy, Laboratories Performing Hemostasis Tests By Market

Segment, 2010

Italy, Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

Italy, Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

Italy, Hospital Laboratories Average Daily Test Volume, 2010

Italy, Commercial/Private Laboratories Average Daily Test

Volume, 2010

Italy, Total Hemostasis Test Volume By Market Segment,

2010-2020

Italy, All Market Segments Hemostasis Test Volume, 2010-2020

Italy, Hospital Laboratories Hemostasis Test Volume, 2010-2020

Italy, Commercial/Private Laboratories Hemostasis Test Volume,

2010-2020

Italy, Hemostasis Reagent Market By Market Segment, 2010-2020

Italy, Major Suppliers of Hemostasis Reagents Estimated Sales

and Market Shares, 2010

Italy, Hemostasis Instrument Market By Market Segment,

2010-2020

Italy, Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

Italy, Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

Italy, Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

Italy, Total Hemostasis Diagnostics Market By Product Category,

2010-2020

Italy, Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

Executive Summary Table: Japan, Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

Japan, Laboratories Performing Hemostasis Tests By Market

Segment, 2010

Japan, Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

Japan, Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

Japan, Hospital Laboratories Average Daily Test Volume, 2010

Japan, Commercial/Private Laboratories Average Daily Test

Volume, 2010

Japan, Total Hemostasis Test Volume By Market Segment,

2010-2020

Japan, All Market Segments Hemostasis Test Volume,

2010-2020

Japan, Hospital Laboratories Hemostasis Test Volume,

2010-2020

Japan, Commercial/Private Laboratories Hemostasis Test

Volume, 2010-2020

Japan, Hemostasis Reagent Market By Market Segment,

2010-2020

Japan, Major Suppliers of Hemostasis Reagents Estimated

Sales and Market Shares, 2010

Japan, Hemostasis Instrument Market By Market Segment,

2010-2020

Japan, Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

Japan, Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

Japan, Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

Japan, Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

Japan, Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

Executive Summary Table: Spain, Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

Spain, Laboratories Performing Hemostasis Tests By Market

Segment, 2010

Spain, Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

Spain, Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

Spain, Hospital Laboratories Average Daily Test Volume, 2010

Spain, Ambulatory Care Centers Average Daily Test Volume, 2010

Spain, Commercial/Private Laboratories Average Daily Test

Volume, 2010

Spain, Total Hemostasis Test Volume By Market Segment,

2010-2020

Spain, All Market Segments Hemostasis Test Volume,

2010-2020

Spain, Hospital Laboratories Hemostasis Test Volume,

2010-2020

Spain, Ambulatory Care Centers Hemostasis Test Volume,

2010-2020

Spain, Commercial/Private Laboratories Hemostasis Test

Volume, 2010-2020

Spain, Hemostasis Reagent Market By Market Segment,

2010-2020

Spain, Major Suppliers of Hemostasis Reagents, Estimated

Sales and Market Shares, 2010

Spain, Hemostasis Instrument Market By Market Segment, 2010

Spain, Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

Spain, Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

Spain, Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

Spain, Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

Spain, Major Suppliers of Hemostasis Diagnostic Products,

Estimates Sales and Market Shares, 2010

Executive Summary Table: U.K., Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

U.K., Laboratories Performing Hemostasis Tests By Market

Segment, 2010

U.K., Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

U.K., Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

U.K., Hospital Laboratories Average Daily Test Volume, 2010

U.K., Commercial/Private Laboratories Average Daily Test

Volume, 2010

U.K., Total Hemostasis Test Volume By Market Segment,

2010-2020

U.K., All Market Segments Hemostasis Test Volume, 2010-2020

U.K., Hospital Laboratories Hemostasis Test Volume, 2010-2020

U.K., Commercial/Private Laboratories Hemostasis Test Volume,

2010-2020

U.K., Hemostasis Reagent Market By Market Segment, 2010-2020

U.K., Major Suppliers of Hemostasis Reagents Estimated Sales

and Market Shares, 2010

U.K., Hemostasis Instrument Market By Market Segment, 2010

U.K., Major Suppliers of Hemostasis Analyzers, Estimated Total

Instrument Placements and Market Shares, 2010

U.K., Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

U.K., Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

U.K., Total Hemostasis Diagnostics Market By Product Category,

2010-2020

U.K., Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

Executive Summary Table: U.S.A., Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

U.S.A., Laboratories Performing Hemostasis Tests By Market

Segment, 2010

U.S.A., Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

U.S.A., Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

U.S.A., Physician Offices/Group Practices Performing Hemostasis

Tests By Practice Size, 2010

U.S.A., Hospital Laboratories Average Daily Test Volume, 2010

U.S.A., Commercial/Private Laboratories Average Daily Test

Volume, 2010

U.S.A., Physician Offices/Group Practices Average Daily Test

Volume

U.S.A., Total Hemostasis Test Volume By Market Segment,

2010-2020

U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020

U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020

U.S.A., Physician Offices/Group Practices Hemostasis Test Volume,

2010-2020

U.S.A., Commercial/Private Laboratories Hemostasis Test Volume,

2010-2020

U.S.A., Hemostasis Reagent Market By Market Segment,

2010-2020

U.S.A., Major Suppliers of Hemostasis Reagents Estimated

Sales and Market Shares, 2010

U.S.A., Hemostasis Instrument Market By Market Segment,

2010-2020

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

U.S.A., Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

U.S.A., Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

To order this report:

In Vitro Diagnostic Industry: Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
2. Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
3. Reportlinker Adds Top Medical Devices and Imaging Technologies 2011
4. Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016
5. Reportlinker Adds UK CT Systems - Market Trend Till 2016
6. Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years
7. Reportlinker Adds US Cardiac Assist Devices -- Market Trend Till 2016
8. Reportlinker Adds Canada Medical Imaging - Market Projections to 2016
9. Reportlinker Adds US Cardiovascular Monitoring Systems - Market Trend Till 2016
10. Reportlinker Adds Global Medical Equipment Rental and Leasing Industry
11. Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):